These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8042814)

  • 21. Comparative measurement of spinal CSF microdialysate concentrations and concomitant antinociception of morphine and morphine-6beta-glucuronide in rats.
    Okura T; Komiyama N; Morita Y; Kimura M; Deguchi Y; Yamada S
    Life Sci; 2007 Mar; 80(14):1319-26. PubMed ID: 17258777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims.
    Bogusz MJ; Maier RD; Driessen S
    J Anal Toxicol; 1997 Sep; 21(5):346-55. PubMed ID: 9288586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of morphine 3-esters after oral administration in rabbits.
    Otter K; Mignat C; Heber D; Ziegler A
    Pharmazie; 2001 Jun; 56(6):471-4. PubMed ID: 11446167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-performance liquid chromatographic determination of morphine, morphine-3-glucuronide, morphine-6-glucuronide and codeine in biological samples using multi-wavelength forward optical detection.
    Chari G; Gulati A; Bhat R; Tebbett IR
    J Chromatogr; 1991 Nov; 571(1-2):263-70. PubMed ID: 1810955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of factors affecting the ratios of morphine and its major metabolites.
    Faura CC; Collins SL; Moore AR; McQuay HJ
    Pain; 1998 Jan; 74(1):43-53. PubMed ID: 9514559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma pharmacokinetics of morphine and morphine-6-glucuronide using high performance liquid chromatography and colorimetric detection].
    Barberi-Heyob M; Merlin JL; Krakowski I; Kettani C; Collin E; Poulain P
    Bull Cancer; 1991 Nov; 78(11):1063-70. PubMed ID: 1369552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.
    Stain-Texier F; Boschi G; Sandouk P; Scherrmann JM
    Br J Pharmacol; 1999 Oct; 128(4):917-24. PubMed ID: 10556926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of acute inflammatory brain injury on accumulation of morphine and morphine 3- and 6-glucuronide in the human brain.
    Roberts DJ; Goralski KB; Renton KW; Julien LC; Webber AM; Sleno L; Volmer DA; Hall RI
    Crit Care Med; 2009 Oct; 37(10):2767-74. PubMed ID: 19865006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure.
    Bodd E; Jacobsen D; Lund E; Ripel A; Mørland J; Wiik-Larsen E
    Hum Exp Toxicol; 1990 Sep; 9(5):317-21. PubMed ID: 2261246
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function.
    Portenoy RK; Thaler HT; Inturrisi CE; Friedlander-Klar H; Foley KM
    Clin Pharmacol Ther; 1992 Apr; 51(4):422-31. PubMed ID: 1563212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients.
    Oosten AW; Abrantes JA; Jönsson S; Matic M; van Schaik RHN; de Bruijn P; van der Rijt CCD; Mathijssen RHJ
    Clin Pharmacokinet; 2017 Jul; 56(7):733-746. PubMed ID: 27815868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of epidural morphine in man.
    Nordberg G; Hedner T; Mellstrand T; Borg L
    Eur J Clin Pharmacol; 1984; 26(2):233-7. PubMed ID: 6723763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma morphine-3-glucuronide, morphine-6-glucuronide and morphine concentrations in patients receiving long-term epidural morphine.
    Schneider JJ; Ravenscroft PJ; Cavenagh JD; Brown AM; Bradley JP
    Br J Clin Pharmacol; 1992 Nov; 34(5):431-3. PubMed ID: 1467139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CSF and plasma pharmacokinetics of intramuscular morphine.
    Nordberg G; Borg L; Hedner T; Mellstrand T
    Eur J Clin Pharmacol; 1985; 27(6):677-81. PubMed ID: 3987773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine.
    Sandouk P; Serrie A; Scherrmann JM; Langlade A; Bourre JM
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():166-71. PubMed ID: 1820872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide.
    Klimas R; Mikus G
    Br J Anaesth; 2014 Dec; 113(6):935-44. PubMed ID: 24985077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of distribution of morphine and metabolites in cerebrospinal fluid and plasma with chronic intrathecal morphine infusion in humans.
    Wallace M; Yaksh TL
    Anesth Analg; 2012 Oct; 115(4):797-804. PubMed ID: 22822192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs.
    KuKanich B; Lascelles BD; Papich MG
    J Vet Pharmacol Ther; 2005 Aug; 28(4):371-6. PubMed ID: 16050817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma and CSF morphine concentrations after i.m. and epidural administration.
    Bellanca L; Latteri MT; Latteri S; Montalbano L; Papa G; Sansone A
    Pharmacol Res Commun; 1985 Feb; 17(2):189-96. PubMed ID: 3991779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.
    Somogyi AA; Nation RL; Olweny C; Tsirgiotis P; van Crugten J; Milne RW; Cleary JF; Danz C; Bochner F
    Clin Pharmacokinet; 1993 May; 24(5):413-20. PubMed ID: 8504624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.